Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice.
New York S00036 amends the education law to allow prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber, at the prescriber's request. This change applies to both dispensing and prescribing labels. The act takes effect immediately.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.